Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The Netherlands
- 20 March 1990
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (12), 27-32
- https://doi.org/10.1016/0002-9149(90)91252-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Dealing with Discounting: An Application to the Cost-Effectiveness of Intracoronary Thrombolysis with StreptokinaseInternational Journal of Technology Assessment in Health Care, 1990
- Cost effectiveness of cholesterol-lowering therapy in The Netherlands: Simvastatin versus cholestyramineAmerican Journal Of Medicine, 1989
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- A Multicenter Comparison of Lovastatin and Cholestyramine Therapy for Severe Primary HypercholesterolemiaPublished by American Medical Association (AMA) ,1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MENThe Lancet, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984